Table 1 Clinico-pathological characteristics of samples
From: Impact of biospecimens handling on biomarker research in breast cancer
ID | ER status* | PR status§ | ERBB2 status^ | Age | Size (cm) | N status |
|---|---|---|---|---|---|---|
Pb1 | + | + | 2+ | 69 | 6 | + |
Pb2 | + | + | 2+ | 85 | 7 | - |
Pb3 | + | + | 2+ | 30 | 2.5 | + |
Pb4 | + | + | 2+ | 46 | 1.1 | - |
Pb5 | + | + | 3+ | 58 | 2.0 | + |
Pb6 | + | + | - | 55 | 2.0 | + |
Pb7 | + | + | 2+ | 57 | 3.0 | + |
Pb8 | - | - | - | 40 | 4.0 | - |
Pb9 | + | + | 1+ | 43 | 6.0 | + |
Pb10 | + | + | - | 54 | 2.2 | - |
Pb11 | + | - | - | 80 | 5.5 | - |